Publications by authors named "Kim Austin"

Claim this Profile
I
Ipilimumab with and without nivolumab in patients with classic Hodgkin lymphoma with progression after PD-1 blockade.
Reid W Merryman, Justin Kline, Robert A Redd, Harrison Olszewski, Emma Welsh, Austin I Kim

Blood Neoplasia· February 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrating single-cell biophysical and transcriptomic features to resolve functional heterogeneity in mantle cell lymphoma.
Ye Zhang, Lydie Debaize, Adam Langenbucher, Jenalyn Weekes, Ioulia Vogiatzi, Austin I Kim

Sci Adv· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trait specialization facilitates autonomous selfing ability in a mixed-mating plant.
Hanna Makowski, Keric Lamb, Austin M Kim, Emily Scott, Laura F Galloway

Am J Bot· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase-2 study of pembrolizumab in patients with biologically selected subtypes of relapsed/refractory aggressive lymphomas.
Mwanasha H Merrill, Robert A Redd, David C Fisher, Jeremy S Abramson, Jeffrey Barnes, Austin I Kim

Leuk Lymphoma· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics and outcomes of patients with double refractory and double exposed chronic lymphocytic leukemia.
James T Yoon, Yinglu Zhou, Mariia Mikhaleva, Daniel S Choi, Stacey M Fernandes, Austin I Kim

Blood Adv· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-cell dynamics of breakthrough toxicities after anakinra prophylaxis for axicabtagene ciloleucel in lymphoma.
Matthew J Frigault, Ning Yao, Trisha R Berger, Marc Wehrli, Kathleen M E Gallagher, Austin I Kim

Blood Adv· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subgroup analysis of older patients ≥60 years with diffuse large B-cell lymphoma in the phase 3 POLARIX study.
Bei Hu, Patrick M Reagan, Laurie H Sehn, Jeff P Sharman, Mark Hertzberg, Austin Kim

Blood Adv· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrating Single-Cell Biophysical and Transcriptomic Features to Resolve Functional Heterogeneity in Mantle Cell Lymphoma.
Ye Zhang, Lydie Debaize, Adam Langenbucher, Jenalyn Weekes, Ioulia Vogiatzi, Austin I Kim

bioRxiv· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum: Phase II Study of Acalabrutinib, Venetoclax, and Obinutuzumab in a Treatment-Naïve Chronic Lymphocytic Leukemia Population Enriched for High-Risk Disease.
Matthew S Davids, Christine E Ryan, Benjamin L Lampson, Yue Ren, Svitlana Tyekucheva, Austin I Kim

J Clin Oncol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II Study of Acalabrutinib, Venetoclax, and Obinutuzumab in a Treatment-Naïve Chronic Lymphocytic Leukemia Population Enriched for High-Risk Disease.
Matthew S Davids, Christine E Ryan, Benjamin L Lampson, Yue Ren, Svitlana Tyekucheva, Austin I Kim

J Clin Oncol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A real-world comparison of commercial-use axicabtagene ciloleucel and lisocabtagene maraleucel in large B-cell lymphoma.
Andrew Looka, David A Qualls, Daniel Matthews, Robert A Redd, Christopher Sakellis, Austin I Kim

Blood Adv· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring the role of antigen-presenting cancer-associated fibroblasts and CD74 on the pancreatic ductal adenocarcinoma tumor microenvironment.
Michael E Thomas, Emily Jie, Austin M Kim, Trenton G Mayberry, Braydon C Cowan

Med Oncol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of IL-22 in cancer.
Zachary E Hunzeker, Lei Zhao, Austin M Kim, Jacob M Parker, Ziwen Zhu

Med Oncol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of atorvastatin versus placebo on efficacy in patients with diffuse large B-cell lymphoma receiving R-CHOP.
Ronald Nemec, Marielle Scherrer-Crosbie, Jeremy S Abramson, Robert Redd, Hannah K Gilman, Austin I Kim

Leuk Lymphoma· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
From bench to bedside: the past, present and future of IL-21 immunotherapy.
Austin M Kim, Lei Zhao, Tej R Patel, Colin J Bailey, Qian Bai

Med Oncol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multi-cohort phase 1b trial of rituximab in combination with immunotherapy doublets in relapsed/refractory follicular lymphoma.
Reid W Merryman, Robert A Redd, Arnold S Freedman, Inhye E Ahn, Jennifer R Brown, Austin I Kim

Ann Hematol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical efficacy and safety of chimeric antigen receptor T-cell therapy for mantle cell lymphoma with secondary central nervous system involvement.
Christine E Ryan, Rebecca L Zon, Robert Redd, David C Fisher, Roni Shouval, Austin I Kim

Br J Haematol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Minimal residual disease in patients with diffuse large B-cell lymphoma undergoing autologous stem cell transplantation.
Reid W Merryman, Robert A Redd, Eleanor Taranto, Gulrayz Ahmed, Erin Jeter, Austin I Kim

Blood Adv· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 2 study of pembrolizumab after autologous stem cell transplantation in patients with T-cell non-Hodgkin lymphoma.
Mwanasha H Merrill, Parastoo B Dahi, Robert A Redd, Mikaela M McDonough, Yi-Bin Chen, Austin I Kim

Blood· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atorvastatin for Anthracycline-Associated Cardiac Dysfunction: The STOP-CA Randomized Clinical Trial.
Tomas G Neilan, Thiago Quinaglia, Takeshi Onoue, Syed S Mahmood, Zsofia D Drobni, Austin I Kim

JAMA· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interim Positron Emission Tomography During Frontline Chemoimmunotherapy for Follicular Lymphoma.
Reid W Merryman, Laure Michaud, Robert Redd, Patrizia Mondello, Hyesun Park, Austin I Kim

Hemasphere· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic value of minimal residual disease among patients with classical Hodgkin lymphoma undergoing autologous stem cell transplantation.
Eleanor Taranto, Robert Redd, Erin Jeter, Kristin McHugh, Jennifer L Crombie, Austin I Kim

Leuk Lymphoma· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Invasive Yeast Infection after Haploidentical Donor Hematopoietic Cell Transplantation Associated with Cytokine Release Syndrome.
Jessica S Little, Roman M Shapiro, Muneerah M Aleissa, Austin Kim, Jun Bai Park Chang

Transplant Cell Ther· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune Reconstitution following High-Dose Chemotherapy and Autologous Stem Cell Transplantation with or without Pembrolizumab Maintenance Therapy in Patients with Lymphoma.
Reid W Merryman, Robert Redd, Erin Jeter, Jeff L Wong, Kristin McHugh, Austin I Kim

Transplant Cell Ther· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Myelopathy Because of CAR-T-Related Neurotoxicity Treated With Siltuximab.
Yasmin Aghajan, Alison Yu, Caron A Jacobson, Austin I Kim, Leslie Kean

Neurol Clin Pract· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis